Volume 71, Issue 3, Pages (February 2007)

Slides:

Advertisements

Similar presentations

Volume 65, Issue 6, Pages (June 2004)

Advertisements

Beta blockers in the management of chronic kidney disease

Microalbuminuria, peripheral artery disease, and cognitive function

The case ∣ A young woman with abdominal discomfort and a mass

High prevalence of chronic kidney disease in Thailand

Obesity, inflammation, and kidney disease

Aging-related inflammation in osteoarthritis

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.

Inflammation and wasting in chronic kidney disease: Partners in crime

Volume 71, Issue 8, Pages (April 2007)

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 70, Pages S21-S25 (December 2006)

The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age B.O. Eriksen, O.C. Ingebretsen Kidney International

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Proinflammatory effects of iron sucrose in chronic kidney disease

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

The epidemiology of chronic kidney disease

Volume 87, Issue 2, Pages (February 2015)

Volume 70, Issue 12, Pages (December 2006)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.

Blood pressure targets in hemodialysis patients

Fructose intake as a risk factor for kidney stone disease

Volume 65, Issue 6, Pages (June 2004)

Volume 72, Issue 12, Pages (December 2007)

The third World Kidney Day: Looking back and thinking forward

Volume 17, Issue 2, Pages (February 1950)

Volume 72, Issue 1, Pages 8-10 (July 2007)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Volume 69, Issue 4, Pages (February 2006)

Methods for guideline development

Volume 76, Issue 1, Pages (July 2009)

The global challenge of chronic kidney disease

Volume 71, Issue 4, Pages (February 2007)

Volume 71, Issue 4, Pages (February 2007)

Fibroblast growth factor 23: the making of a hormone

A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE L.F. Quintana, B. Guzmán, S. Collado,

Leptin and inflammation-associated cachexia in chronic kidney disease

Cardio-Kidney-Damage: a unifying concept

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

Volume 72, Issue 8, Pages (October 2007)

Is it the low-protein diet or simply the salt restriction?

The hypothesis that abnormal BH4 metabolism impairs kidney function

Urinalysis in Western culture: A brief history

Volume 70, Issue 3, Pages (August 2006)

Volume 71, Issue 9, Pages (May 2007)

Fetuin-A is not associated with mortality in chronic kidney disease

Volume 70, Issue 5, Pages (September 2006)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 72, Issue 11, Pages (December 2007)

Adiponectin: good, bad, or just plain ugly?

Hisataka Kobayashi, Peter L. Choyke Kidney International

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 69, Issue 8, Pages (April 2006)

Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Volume 72, Issue 12, (December 2007)

Sugar-sweetened beverages and chronic disease

Update on Cystatin C: Incorporation Into Clinical Practice

Presentation transcript:

Volume 71, Issue 3, Pages 239-244 (February 2007) Kidney function and markers of inflammation in elderly persons without chronic kidney disease: The health, aging, and body composition study C.R. Keller, M.C. Odden, L.F. Fried, A.B. Newman, S. Angleman, C.A. Green, S.R. Cummings, T.B. Harris, M.G. Shlipak Kidney International Volume 71, Issue 3, Pages 239-244 (February 2007) DOI: 10.1038/sj.ki.5002042 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Associations of Cystatin C with (a) CRP, (b) IL-6 and (c) TNF-α. (a–c) Plots of cystatin C versus log-transformed inflammatory markers with fitted line (P<0.0005 for all). Kidney International 2007 71, 239-244DOI: (10.1038/sj.ki.5002042) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Mean values of biomarkers in subjects with cystatin C<1.0 and cystatin C≥1.0mg/l. Error bars represent s.e.m. Kidney International 2007 71, 239-244DOI: (10.1038/sj.ki.5002042) Copyright © 2007 International Society of Nephrology Terms and Conditions